Appendix 3Y Change of Director’s Interest Notice Rule 3.19A.2 Appendix 3Y Change of Director’s Interest Notice Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public. Introduced...
Appendix 3Y Change in Director Interest - D Gill
Filed with ASX · · 2 pages · English
Release
Telix Pharmaceuticals Limited on 6ix
Earlier from Telix Pharmaceuticals
- Telix Reports Third Quarter 2026 Financial Performance
- Telix Highlights Pivotal Trials in Prostate, Brain and Renal Cancers and Next Generation Theranostics at EANM
- Telix to Host Capital Markets Day in Melbourne on November 4, 2026
- First Patients Dosed with Telix’s FDA-Approved Brain Cancer Imaging Drug Pixclara (floretyrosine F 18)
- Notification of cessation of securities - TLX
Later from Telix Pharmaceuticals
- Appendix 3Y William Jellison
- Appendix 3Y Dr Christian Behrenbruch
- Application for quotation of securities - TLX
- Telix Notice of General Meeting, Proxy Form and Online Guide
- Notice of General Meeting
